Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

C Berthet; O Raguin; S Chalon; X Tizon; S Serrière; P Provent; M Hillairet de Boisferoni; G Serini; J Vercouillie; C Mothes; F Gourand; L Barré; D Guilloteau; P Blom; J Hoflack; P. Genne

Poster communications

Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

C Berthet O Raguin S Chalon X Tizon S Serrière P Provent M Hillairet de Boisferoni G Serini J Vercouillie C Mothes F Gourand ¹ L Barré ¹ D Guilloteau P Blom J Hoflack P. Genne

1 ISTCT - Imagerie et Stratégies Thérapeutiques des pathologies Cérébrales et Tumorales

Document type :

Poster communications

Domain :

Life Sciences [q-bio]

Chemical Sciences

Chemical Sciences / Radiochemistry

Complete list of metadata

https://hal-normandie-univ.archives-ouvertes.fr/hal-02386511
Contributor : Carole Brunaud Connect in order to contact the contributor
Submitted on : Friday, November 29, 2019 - 1:04:45 PM
Last modification on : Tuesday, March 29, 2022 - 6:26:02 PM

Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

Identifiers

Collections

Citation

Export

Metrics

22

Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

Identifiers

Collections

Citation

Export

Share

Metrics

22